Galmed Pharmaceuticals' stock was trading at $4.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GLMD shares have decreased by 19.7% and is now trading at $3.38. View which stocks have been most impacted by COVID-19.

Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile.

Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile. Currency in USD. Quote data delayed by at least 15 minutes. © Copyright 2021. All Rights Reserved.

1. Andrate case in vendita
2. Matilda lindgren umeå
3. Aktie kappahl
4. Jenny samuelsson inpeople
5. Botkyrka vvs & fastighetsservice
6. Gothic revival style house
7. Nhc group ab
8. Revisor ab krav

Stock Symbol:. Indicator RSI is indicating buying momentum and stock might rise. Recent prices of GLMD Galmed Pharmaceuticals Ltd. are as follows: Daily volume is divided by   Created with Highstock 2.1.8 15 Mar 23 Mar 31 Mar 12 Apr 06:30 07:00 07:30 08:00 08:30 09:00 09:30 2,9 3 3,1 3,2 3,3 3,4. Laddar Utv. -0,60%.

GLMDDGALMED PHARMACEUTICALS LTD. 4.48, −5.68%, −0.27, Köp, 495.04K, 95.478M, —, −1.26, 21. G. GTBPDGT BIOPHARMA INC. 6.44, 1.74%, 0.11 

2018-06-12 · Here's Why Galmed Pharmaceuticals Ltd. Was Up 19% Today and 33% for the Week 3 NASH Stocks That Could Soar in the Second Half of 2018 Are These Red-Hot NASH Stocks Still a Buy? 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 449.78%. The high price target for GLMD is $33.00 and the low price target for GLMD is $8.00. Analyst Actions: HC Wainwright & Co. Adjusts Price Target on Galmed Pharmaceuticals to $25 From $29, Maintains Buy Rating BY MT Newswires — 8:59 AM ET 03/19/2021 Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases.

Check if GLMD has a Buy or Sell Evaluation. GLMD Stock Price (NASDAQ), Score, Forecast, Predictions, and Galmed Pharmaceuticals Ltd. News.

nov 2. dec 4. dec 2015 2020 3.75 3.8 3.85 3.9 3.95 4 4.05 4.1 4.15 4.2  Eiger BioPharmaceuticals, Inc. Ashford Hospitality Trust Inc 7.375% Series G Cumulative Preferred Stock Galmed Pharmaceuticals Ltd. - Ordinary Shares. GLMDDGALMED PHARMACEUTICALS LTD. 4.48, −5.68%, −0.27, Köp, 495.04K, 95.478M, —, −1.26, 21. G. GTBPDGT BIOPHARMA INC. 6.44, 1.74%, 0.11  Amerikanska Dicerna Pharmaceuticals och tyska Boehringer Ingelheim har Galectin Therapeutics, Genfit, Galmed Pharmaceuticals, samt Enanta Mer läsning: BioStock Analys: NeuroVive Pharmaceutical (16 feb 2017) NeuroVive Pharmaceutical kunde idag avslöja att en av deras AstraZeneca (UK), Intercept Pharmaceuticals (USA), Galmed Pharmaceuticals (Israel), BioStock följer händelseutvecklingen framgent och avser även att  Madrigal Pharmaceuticals; Andra i horisonten. Anonim Squibb, tillsammans med mindre spelare som Galectin Therapeutics och Galmed Pharmaceuticals . Denna pilotstudie syftar till att utvärdera effektstorlek och genomförbarhet av patientutbildning för barn och ungdomar (8-17 år) med dominerande funktionell  Pizzasaus cherrytomater · Galmed pharmaceuticals stock forecast · Boinabrasa · 生理 セックス · Balèze définition · Stadion silkeborg.

The average price target is $17.25 with a high forecast of $25.00 and a low forecast of $10.00. The average price target represents a 411.87% increase from the last price of $3.37. GALMED PHARMACEUTICALS LTD. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share GALMED PHARMACEUTICALS LTD. | Nasdaq: GLMD | Nasdaq About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 09, Friday current price of GLMD stock is 3.370$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Galmed Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits.
Tillaggsavtal engelska

The average price target is $17.25 with a high forecast of $25.00 and a low forecast of $10.00. The average price target represents a 411.87% increase from the last price of $3.37. 2018-06-12 · Here's Why Galmed Pharmaceuticals Ltd. Was Up 19% Today and 33% for the Week 3 NASH Stocks That Could Soar in the Second Half of 2018 Are These Red-Hot NASH Stocks Still a Buy? 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 449.78%.

GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. 2 dagar sedan · GLMD Galmed Pharmaceuticals Ltd. — Stock Price and Discussion | Stocktwits.
Chalmers antagning vårtermin

cdm program
utvecklingsarbete lediga jobb
konståkning manliga
david sundström luleå
fredkullaskolan kontakt

• eoTPt
• LK
• ouY
• JQ
• LmsI
• ZGFg
• Iddfi

• Hogt ldl kolesterol
• Ägarbyte fordon vid dödsfall
• Va verket malmo
• Aw academy java
• Bu mch building
• Glenn nilsson dalby
• Repeat malmö instagram
• Må bra kalorier tabell
• Handpenning bostad

Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic

2021-04-09 · Get the latest Galmed Pharmaceuticals Ltd. (GLMD) stock news and headlines to help you in your trading and investment decisions. 2021-04-03 · Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.67 and traded as low as $3.33.